p53- and CD95-associated apoptosis in neurodegenerative diseases

Laboratory Investigation

Volumn 78, Issue 4, 1998, Pages 401-411

  De La Monte, Suzanne M ^a,b   Sohn, Yoon K ^a   Ganju, Neema ^b   Wands, Jack R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN P53;

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA DAMAGE; DOWN SYNDROME; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; DNA FRAGMENTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEURODEGENERATIVE DISEASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031959496     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, and Struhl K, editors (1997). Current protocols in molecular biology. New York: John Wiley & Sons.
2. Bishop M and de la Monte SM (1989). Dual lineage of astrocytomas. Am J Pathol 135:517-528.
3. Buttke TM and Sandstrom PA (1994). Oxidative stress as a mediator of apoptosis. Immunol Today 15:7-10.
4. Clement MV and Stamenkovic I (1996). Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 15: 216-225.
5. de la Monte SM (1989a). Uniform lineage of oligodendrogliomas. Am J Pathol 135:529-540.
6. de la Monte SM (1989b). Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25:450-459.
7. de la Monte SM and Bloch KD (1997). Aberrant expression of the constitutive endothelial nitric oxide synthase gene expression in Alzheimer's disease. Mol Chem Neuropathol 30:139-159.
8. de la Monte SM, Ng S-C, and Hsu DW (1995). Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 147:934-946.
9. de la Monte SM, Sohn Y-K, and Wands JR (1997). Correlates of p53 and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152:73-83.
10. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, and Mee E (1995). In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6:1053-1057.
11. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, and Schwartz M (1995). Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J 14:1136-1144.
12. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, and Schwartz M (1996). p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol Cell Biol 16:5178-5185.
13. Ellis RE, Yuan J, and Horvitz HR (1991). Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698.
14. Enari M, Hug H, and Nagata S (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81.
15. Eseri MM and Morris JH, editors (1997). The neuropathology of dementia. Cambridge, England: Cambridge University Press.
16. Gavrieli YSY and Ben-Sasson SA (1992). Identification of programmed cell death via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
17. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, and Araoz C (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
18. Gurney ME, Pu H, Chiu AY, Dal CM, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Zhai P, Swift RL, and Siddique T (1994). Motor neuron degeneration in mice that express a human Cu-Zn superoxide dismutase mutation. Science 264:1772-1775.
19. Itoh N, Yonehara S, Ishii A, Mizuchima SI, Sameshima M, Hase A, Seto Y, and Nagata S (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243.
20. Jensen LM, Zhang Y, and Shooter EM (1992). Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivation-induced apoptosis in human neuroblastoma cells. J Biol Chem 267:19325-19333.
21. Lowry OH, Rosebrough NJ, Farr AI, and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. Messmer UK, Ankarcrona M, Nicotera P, and Brune B (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355:23-26.
23. Migheli A, Cavalla P, Marino S, and Schiffer D (1994). A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53:606-616.
24. Miller RH, Abney E, David S, French-Constant C, Lindsay R, Patel R, Stone J, and Raff MC (1986). Is reactive gliosis a property of a distinct subpopulation of astrocytes? J Neurosci 6:22-29.
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, and Berg L (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486.
26. Miura M, Zhu H, Rotello R, Hartwieg EA, and Yuan J (1995). Induction of apoptosis in fibroblasts by IL10-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
27. Nagata S and Goldstein P (1995). The Fas death factor. Science 267:1449-1456.
28. Nishimura T, Akiyama H, Yonehara S, Kondo H, Ikeda K, Kato M, Iseki E, and Kosaka K (1995). Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 695:137-145.
29. Pittman RN, Wang S, DiBenedetto AJ, and Mills JC (1993). A system for characterizing cellular and molecular events in programmed neuronal cell death. J Neurosci 13:3669-3680.
30. Raff MC and Miller RH (1984). The in vitro differentiation of a bipotential glial progenitor cell. EMBO J 3:1857-1864.
31. Rosenbaum DM, Michaelson M, Batter DK, Doshi P, and Kessler JA (1994). Evidence for hypoxia-induced programmed cell death of cultured neurons. Ann Neurol 36:864-870.
32. Rubin LL, Gatchalian CL, Rimon G, and Brooks SF (1994). The molecular mechanisms of neuronal apoptosis. Curr Opin Neurobiol 4:696-702.
33. Smale G, Nichols NR, Brady DR, Finch CE, and Horton WE Jr (1995). Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
34. Su JH, Anderson AJ, Cummings BJ, and Cotman CW (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533.
35. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, and Lee VM (1996). Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 93:3155-3160.
36. Xu Y-Y, Wands JR, and de la Monte SM (1993). Characterization of thread proteins expressed in neuroectodermal tumors. Cancer Res 53:3823-3829.
37. Yuan J, Shaham S, Ledoux S, Ellis HM, and Horvitz HR (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-Iβ-converting enzyme. Cell 75:641-652.